Targeted therapy in melanoma: From response to resistance
Professor Kieran Smalley from the MOFFITT Cancer Centre in Tampa, Florida, will be visiting the TRI on the 18th October to deliver a featured seminar on Melanoma treatment.
The goal of research in the Smalley laboratory is to develop personalized therapies for melanoma, the deadliest form of skin cancer. Over the past few years our lab has used genetic and mutational profiling data to define two new sub-groups of melanoma and have identified therapeutic strategies for each.
Join us in the TRI Auditorium on Tuesday 18 October at noon for this featured seminar.
Prof Kieran Smalley
MOFFITT Cancer Centre
Tampa Florida
